✨ Your Portfolio is fetched and updated from zerodha.
Micro
Market Cap
₹1,223 Cr.
P/E
25.66

Key Ratios

Market cap
Market cap
1,223 Cr
PE
PE
25.66
Prom Holding
Prom Holding
65.57 %
ROE (%)
ROE (%)
20.14
ROCE (%)
ROCE (%)
21.80
Div Yield (%)
Div Yield (%)
1.64
Sales
Sales
416 Cr
OPM (%)
OPM (%)
19.87 %
Debt to Equity
Debt to Equity
0.05
About
GPT Healthcare Limited is a provider of integrated healthcare services through a chain of mid-… Read more
Low
138
52W Range
High
199
  • GPT Healthcare
  • KMC Speciality Hosp
  • Suraksha Diagnostic

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on GPT Healthcare Ltd. Business

GPT Healthcare Limited is engaged in the business of providing healthcare services. The company operates a chain of mid-sized full service hospitals under the brand and provides integrated healthcare services, with a focus on secondary and tertiary care. The Principal activities of the company include operation of multidisciplinary private hospitals and pharmacies. It offers a comprehensive range of healthcare services across many specialties and super specialties, including internal medicine and diabetology, nephrology (including renal transplants), laparoscopic and general surgery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics and neonatology.

GPT Healthcare major competitors are KMC Speciality Hosp, Suraksha Diagnostic, Shalby, Dr Agarwals Eye Hsp, Vaidya Sane Ayur Lab, Nephro Care India, Unihealth Hospitals.
Market Cap of GPT Healthcare is ₹1,216 Crs.
While the median market cap of its peers are ₹1,119 Crs.

GPT Healthcare seems to be less financially stable compared to its competitors.
Altman Z score of GPT Healthcare is 6.56 and is ranked 5 out of its 8 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release May Aug Mar Jun Sep Dec Dec
Investor Presentation May Aug Mar Jun Sep Dec Dec Sep
Conference Call Mar Jun Jan Mar Jun Sep Dec
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material